Expertise in
4
conditions

Kjersti Flatmark

Oslo, NO 
Expertise in
4
conditions
Oslo, NO 

Overview

Kjersti Flatmark practices practicing medicine in Oslo, Norway.

Ms. Flatmark is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Pseudomyxoma Peritonei, Colorectal Cancer, Cerebral Hypoxia, Hepato-Pancreato-Biliary Surgery, and Hepatectomy.

She is actively involved in clinical research, co-authoring 127 peer reviewed articles and participating in 4 clinical trials.

Gender

Female

Locations

Oslo, Norway
Other Locations
Nydalen, 0424, Norway
Blindern, 0318, Norway

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

METIMMOX: Colorectal Cancer METastasis - Shaping Anti-tumor IMMunity by OXaliplatin
METIMMOX: Colorectal Cancer METastasis - Shaping Anti-tumor IMMunity by OXaliplatin
Enrollment Status: Completed
Publish Date: February 13, 2026
Intervention Type: Drug
Study Phase: Phase 2
Computer Navigation-assisted Surgery for Locally Advanced and Recurrent Rectal Cancer
Computer Navigation-assisted Surgery for Locally Advanced and Recurrent Rectal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: November 14, 2022
Intervention Type: Device
Study Phase: Not Applicable
Prospective Observational Study of Exfoliated Peritoneal Tumor Cells in Locally Advanced Rectal Cancer
Prospective Observational Study of Exfoliated Peritoneal Tumor Cells in Locally Advanced Rectal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 28, 2021
Intervention Type: Other
Phase I/II Trial of MOC31PE Immunotoxin in Peritoneal Carcinomatosis From Colorectal Carcinoma
Phase I/II Trial of MOC31PE Immunotoxin in Peritoneal Carcinomatosis From Colorectal Carcinoma
Enrollment Status: Completed
Publish Date: May 30, 2017
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 3 Less Clinical Trials

127 Total Publications

Pooled analysis of 2 clinical trials of first-line chemoimmunotherapy for metastatic microsatellite stable colorectal cancer MEDITREME and METIMMOX studies.
Pooled analysis of 2 clinical trials of first-line chemoimmunotherapy for metastatic microsatellite stable colorectal cancer MEDITREME and METIMMOX studies.
Journal: Oncoimmunology
Published: June 20, 2026

Frequently Asked Questions about Kjersti Flatmark

Is Kjersti Flatmark a top-rated expert for Pseudomyxoma Peritonei?

MediFind is an objective health platform that identifies experts based on real-world data. Kjersti Flatmark is classified as an Distinguished expert for Pseudomyxoma Peritonei, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Kjersti Flatmark participate in research or clinical trials?

Yes. Kjersti Flatmark has published 127 articles and abstracts on conditions like Pseudomyxoma Peritonei. You can view a list of Kjersti Flatmark's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Flatmark's expertise for a condition
ConditionClose
    View All 12 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile